ConsultantLive Members: Login | Register
 |  |
ConsultantLive SearchMedica Medline Drugs

Powered by SearchMedica

 
About Us
Blogs
Dermclinic
Photoclinic
Pediatric Center
Multimedia
What's Your Diagnosis?
Jobs
Buyer's Guide
 

Home » Cardiovascular Diseases

ConsultantLive.com.
Pages: 1  2  3  
Previous
 

Hyperlipidemia: How to Optimize Risk While Waiting for NCEP ATP IV Guidelines

By Seth S Martin, MD | July 27, 2012
Dr Martin is a Cardiology Fellow in the Division of Cardiology at The Johns Hopkins Hospital in Baltimore, Maryland and an investigator in the Ciccarone Center for the Prevention of Heart Disease, also in Baltimore.

Recommendation #7: Refine therapeutic target levels to the equivalent population percentile.
ATP III set non-HDL-C goals 30 mg/dL higher than LDL-C goals
     • With this approach, non-HDL-C goals are higher than the equivalent population percentile for an equivalent LDL-C goal.
     • Equivalent goals based on population percentiles are:
        » LDL-C <70 mg/dL = non-HDL-C <90 mg/dL = apoB <60 mg/dL
        » LDL-C <100 mg/dL = non-HDL-C <120 mg/dL = apoB <80 mg/dL

Recommendation #8: Remove misleading descriptors such as “borderline high.”
ATP III labels a LDL-C of 130 to 159 mg/dL as “borderline high”
     • Consider: Average LDL-C levels range from 50 to 70 mg/dL in groups naturally free of atherosclerosis (these include native hunter-gatherers, healthy human neonates, free-living primates, and other wild mammals)
     • The value range described as “borderline high” is 2 to 3 times higher than humans have evolved to have, is not evidence-based, and provides false reassurance to patients whose LDL-C is actually dangerously high; either the ranges or descriptors need reassessment
     • We recommend removing the misleading descriptors or reframing lipid levels in the context of normal levels by evolutionary, rather than modern American, standards  

(MORE: Novel Risk Factors Improve Prediction of Cardiovascular Disease in Intermediate-Risk Persons)

Recommendation #9: Make lifestyle messages simpler, “user-friendly.”
Try telling a patient: “Up to 10% of your total calories should be from polyunsaturated fat, up to 20% from monounsaturated fat,” and so on. Not effective communication.
     • Here are lifestyle messages that are evidence-based and that we find helpful in clinic:
        » Diet
             • Rather than nutrient percentages, emphasize a dietary pattern
             • Encourage patients to follow a DASH–like (Mediterranean-style) diet10 
                  • Associated with reduced cardiovascular and all-cause mortality
                  • Easy to discuss with a patient: increase consumption of fresh fruits, vegetables, whole grains, low-fat dairy, oily fish, poultry over red meat; eat a modest amount of nuts and beans, herbs and spices in place of salt, and limit added fats (eg, olive oil in place of butter and margarine)
             • Patients can use cookbooks following a DASH-like eating pattern
     • Exercise
             • Advise patients to wear a pedometer with a goal of 10,000 steps/day
             • This intervention is linked with increased exercise and improved health

Recommendation #10: Adopt an ABCDE approach in clinic.
     • Optimizing risk reduction in a busy primary care clinic is as easy as ABC, D, and E!
        » A: Assessment of risk, Aspirin/antiplatelet therapy, Affordability, ACE-I/ARB, Apnea
        » B: Blood pressure, Beta-blocker
        » C: Cholesterol, Cigarette smoking
        » D: Diet, Diabetes
        » E: Exercise  
    

 • As a nod to this approach, here are our ATP IV recommendations, summarized in ABDCE format:
        » A: Assessment of risk - use a more comprehensive, accurate approach
        » A: Algorithm - directly link risk to therapy; relax/personalize follow-up testing
        » B: Biology - consider particles vs. cholesterol, use evolutionarily normal lipid levels
        » C: Cholesterol - deemphasize baseline cholesterol as a starting point in algorithms
        » D: Drug classes - prioritize statins
        » D: Descriptors - remove them; they are misleading
        » D: Diet - convey a simpler message (eg, a DASH-like or Mediterranean diet)
        » E: Exercise - convey a simpler message (eg, 10 000 steps/day)

Scroll down for References

Pages: 1  2  3  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More on this topic

Statins Linked to Exertional Fatigue in New Study

Statins and the New FDA Warnings: What Does It All Mean for Your Patients?

Statin Therapy and Oral Antidiabetic Drugs: On Adherence and Initiation

Hyperlipidemia: How to Optimize Risk While Waiting for NCEP ATP IV Guidelines

Systemic Inflammation and Use of Diet to Stem Disease

Omega-3 Fatty Acid Therapy: What Comes Next?

Novel Risk Factors Improve Prediction of Cardiovascular Disease in Intermediate-Risk Persons





References
1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.  

2. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction.Circulation.2007;116:e148-e304.

3. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. NEJM. 2005;352:1425-1435.

4. Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294:2437-2445.

5. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. NEJM. 2008;359:2195-2207.

6. Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS guidelines for the management of dyslipidaemias; the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011;217:3–46.

7. Marcovina SM, Albers JJ, Kennedy H, et al. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material. Clin Chem. 1994;40:586-592.

8. Brunzell JD, Davidson M, Furberg CD,et al; American Diabetes Association; American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008;31:811-822.

9. Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can J Cardiol. 2009;25:567–579.

10. Parikh P, McDaniel MC, Ashen MD, et al. Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol. 2005;45:1379 –1387.


Other very important papers, on lifetime risk:
Lloyd-Jones DM, Leip EP, Larson MG, et al.. Prediction of lifetime risk for cardiovascular
disease by risk factor burden at 50 years of age. Circulation 2006;113:791–798

Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease.  N Engl J Med. 2012;366:321-329.


 
TOPIC INDEX

Asthma

Atrial Fibrillation

Cardiovascular

Cerebrovascular

Developmental/Genetic

Diabetes

Diabetes Type 2

Fibromyalgia

Geriatrics

GI Disorders

Gout

Health Care Reform

HIV/AIDS

Hypertension

Infection

Mental Health

 

Musculoskeletal

Nervous System

Nutritional/Metabolic 

Otorhinolaryngologic 

Pain

Pediatrics

Physical Abuse

Respiratory Tract 

Rheumatic Diseases

Seasonal Allergies

Skin Diseases

Sleep Disorders

Urologic Diseases

Vaccines

Women’s Health

All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Why Doctors Commit Suicide
  • T-Wave Inversions: Sorting Through the Causes
  • Ecchymosis: A Photo Essay
  • Go For The Glory Quiz: Xanthomata, Foreign Body Aspiration, Drug Interactions, Fingernail Clubbing
  • New Diabetes Algorithm Geared to Primary Care
  • Why Doctors Commit Suicide
  • New Diabetes Algorithm Geared to Primary Care
  • Tuberculosis Diagnosis With Handheld Device
  • Alternate-Day Statin Therapy
  • Some Do’s and Don’ts for Tough-to-Treat Hypertensives
  • Betatrophin: The Finding that Eliminates Diabetes Or Just Another Alluring Promise?
  • Preventing Hypertension: Do Primary Care Providers Practice What They Prescribe?
  • ASH 2013: Post Script
  • Reflections on ASH 2013: Lessons in Quality Improvement
  • Treating Hypertension in the Hospital: A Few Scenarios that Challenge Primary Care
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Why Doctors Commit Suicide
  • Hypertension Disorders—A Photo Essay
  • Wanted: Physician Feedback on Medical Cannabis
  • Making the Most of Antihypertensive Drug Combinations
  • Medical Training for the 1%
  • Making the Most of Antihypertensive Drug Combinations
  • A Requiem for Beta Blockers to Treat Hypertension?
  • Wanted: Physician Feedback on Medical Cannabis
  • Some Do’s and Don’ts for Tough-to-Treat Hypertensives
  • Oro-labial Herpes Simplex (“Cold Sores”)
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Cardiovascular Diseases
Evidence on Cardiovascular Diseases
Guidelines on Cardiovascular Diseases
Patient Education on Cardiovascular Diseases
Clinical Trials on Cardiovascular Diseases
Practical Articles on Cardiovascular Diseases
Research and Reviews on Cardiovascular Diseases
All "Cardiovascular Diseases" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy